QVT
REGN icon

Quantitative Value Technologies’s Regeneron Pharmaceuticals REGN Stock Holding History

Quantitative Value Technologies’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$395K Sell
708
-49
-6% -$24.8K 0.65% 43
2021
Q1 		$358K Buy
+757
New +$369K 0.77% 67

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Quantitative Value Technologies's REGN Position: Q2 2021 in Review

Quantitative Value Technologies reduced its Regeneron Pharmaceuticals (REGN) stake by 6.5% in Q2 2021, selling an estimated $24.8K and leaving 708 shares worth $395K. The position accounts for 0.65% of the portfolio, ranked #43.

Quantitative Value Technologies first reported a position in REGN in Q1 2021 and has held it in 2 quarters since. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

  • Quantitative Value Technologies held 708 shares of Regeneron Pharmaceuticals worth $395K as of Q2 2021.
  • Quantitative Value Technologies sold 49 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $24.8K.
  • Regeneron Pharmaceuticals made up 0.65% of Quantitative Value Technologies's portfolio in Q2 2021, its #43 holding.
  • Quantitative Value Technologies first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 2 quarters since.
  • 971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on Quantitative Value Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.